News

Lonza gets InterHealth

14 Sep 2016

Lonza has closed the acquisition of InterHealth Nutraceuticals, who operate in the research, development, manufacture and marketing of proprietary, value-added nutritional ingredients for use in dietary supplements.

Lonza has closed the acquisition of InterHealth Nutraceuticals. Interhealth operates in the research, development, manufacture and marketing of proprietary, value-added nutritional ingredients for use in dietary supplements, and is based in Benicia, CA (USA).

The InterHealth business will become part of Lonza’s Consumer Care Business Unit, but will retain its facilities and employees. The combination of the two businesses allows Lonza to offer InterHealth’s more than 15 branded ingredients, including its cornerstone joint health ingredient, UC-II.

“We are looking forward to welcoming the highly capable team to our Lonza family. They nicely complement our offerings and will be joining us in our quest to becoming the world’s leading and most-trusted supplier to the pharmaceutical, biotech and specialty ingredients markets.” said Richard Ridinger, Lonza’s Chief Executive Officer. “Lonza will be able to harness the proven management and branding capabilities and leverage them to a global level.”

Lonza acquired InterHealth for a total transaction price of up to $300 million. The transaction is expected to be immediately accretive to Lonza’s earnings.